Met Life Investment Management, LLC Werewolf Therapeutics, Inc. Transaction History

Met Life Investment Management, LLC

  • $17.1 Billion
  • Q3 2024

Shares

5 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2022

May 12, 2022
SELL
$3.71 - $12.22 $42,371 - $139,564
-11,421 Closed
0 $0
Q4 2021

May 17, 2024
BUY
$11.48 - $17.65 $131,113 - $201,580
11,421 New
11,421 $136,000
Q4 2021

Jun 21, 2023
BUY
$11.48 - $17.65 $131,113 - $201,580
11,421 New
11,421 $136,000
Q4 2021

Mar 22, 2023
BUY
$11.48 - $17.65 $131,113 - $201,580
11,421 New
11,421 $136,000
Q4 2021

Feb 15, 2022
BUY
$11.48 - $17.65 $131,113 - $201,580
11,421 New
11,421 $136,000

Others Institutions Holding HOWL

# of Institutions
68
Shares Held
31.8M
Call Options Held
700
Put Options Held
500
View Full List

About Werewolf Therapeutics, Inc.

HOWL Quotes by TradingView
  • Ticker HOWL
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 29,529,400
  • Market Cap $39.9M
  • Description
  • Werewolf Therapeutics, Inc., a biopharmaceutical company, develops therapeutics engineered to stimulate the body's immune system for the treatment of cancer. The company, through its proprietary PREDATOR platform, designs conditionally activated molecules that stimulate adaptive and innate immunity for addressing the limitations of conventional ...
More about HOWL
Track This Portfolio

Track Met Life Investment Management, LLC Portfolio

Follow Met Life Investment Management, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Met Life Investment Management, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Met Life Investment Management, LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email